Why the study?
Does an intensive course of inhaled iloprost and sildenafil improve symptoms and resolve pericardial effusion in an adult with unrepaired ventricular septal defect and severe pulmonary arterial hypertension?
Does an intensive course of inhaled iloprost and sildenafil improve symptoms and resolve pericardial effusion in an adult with unrepaired ventricular septal defect and severe pulmonary arterial hypertension?
Intensive inhaled iloprost may serve as an effective rescue therapy for severe pulmonary arterial hypertension when intravenous prostacyclin is unavailable.
Answers are grounded in this paper and cite their sources.
May support inhaled iloprost rescue in unrepaired VSD-PAH; hypothesis-generating and should not yet change practice.
A 38-year-old male was diagnosed with unrepaired ventricular septal defect associated with severe pulmonary arterial hypertension, cyanosis, and significant exercise intolerance. His echocardiogram showed right ventricular dysfunction and moderate pericardial effusion with no signs of cardiac tamponade. He was treated with an intensive course of inhaled iloprost and sildenafil. He showed a dramatic clinical response; his saturation went up from 60% on admission to 90% on minimal oxygen with significant improvement in his symptoms and signs of heart failure and total resolution of pericardial effusion. On follow up 3 and 6 weeks later, he was stable and could walk 360 meters in a 6 minutes walk test with disappearance of pericardial effusion. With unavailability of intravenous prostacyclin, we have shown in this case that intensive administration of inhaled iloprost could be used intensively as a rescue therapy in severe cases of pulmonary arterial hypertension with excellent results.
No takes yet. Share an insight, caveat, or question.
Alzahrani et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: